KVP Capital Advisors, LP
Registered adviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Sep 2026 to Oct 2026 | $220,949,271 | Pooled investment vehicles (100%) |
| Apr 2026 to Jun 2026 | — | — |
| Apr 2025 to Mar 2026 | — | — |
| Apr 2024 to Mar 2025 | — | — |
| Jun 2023 to Mar 2024 | — | — |
| May 2023 | $0 | — |
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2026-06-30, active share 97.9%; sector active share 90.9% against the combined 13F book's sector weights.
Over time 3 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
35 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $136,239,625 |
Last Quarter's Activity
Export CSVNew Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TNDM | Tandem Diabetes Care Inc | 301,000 | $4,542,090 | |
| AVBP | ArriVent BioPharma, Inc. | 102,000 | $3,543,480 | |
| DSGN | Design Therapeutics, Inc. | 185,000 | $2,676,950 | |
| MLYS | Mineralys Therapeutics, Inc. | 84,168 | $2,270,852 | |
| ARTV | Artiva Biotherapeutics, Inc. | 200,000 | $1,940,000 | |
| EOLS | Evolus, Inc. | 150,000 | $1,041,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| — | 440,000 | $23,196,800 | ||
| RVMD | Revolution Medicines, Inc. | 40,200 | $3,909,450 | |
| — | 59,700 | $1,998,756 | ||
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 42,900 | $14,362,491 | 10.54% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Held | 2,165,997 | $9,920,266 | 7.28% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 455,000 | $8,335,600 | 6.12% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 414,000 | $7,721,100 | 5.67% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Held | 226,575 | $7,522,290 | 5.52% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Held | 230,264 | $7,198,052 | 5.28% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Held | 121,524 | $6,708,124 | 4.92% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 53,000 | $6,496,740 | 4.77% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 133,000 | $5,403,790 | 3.97% | |
| TNDM |
Tandem Diabetes Care Inc
Healthcare
|
NEW | 301,000 | $4,542,090 | 3.33% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Held | 58,250 | $4,260,405 | 3.13% | |
| SVRA |
Savara Inc
Healthcare
|
Held | 605,280 | $3,728,524 | 2.74% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
NEW | 102,000 | $3,543,480 | 2.60% | |
| INSM |
INSMED Inc
Healthcare
|
Held | 28,497 | $3,038,350 | 2.23% | |
| ACHV |
Achieve Life Sciences, Inc.
Healthcare
|
Held | 462,355 | $3,019,178 | 2.22% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Held | 79,700 | $2,970,419 | 2.18% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Held | 300,000 | $2,946,000 | 2.16% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 12,000 | $2,937,240 | 2.16% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
NEW | 185,000 | $2,676,950 | 1.96% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Held | 4,750 | $2,573,692 | 1.89% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 45,000 | $2,475,000 | 1.82% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
Held | 230,423 | $2,375,661 | 1.74% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Held | 125,000 | $2,296,250 | 1.69% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
NEW | 84,168 | $2,270,852 | 1.67% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Held | 31,813 | $2,233,272 | 1.64% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Reduced | 39,000 | $2,215,590 | 1.63% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Held | 373,128 | $2,201,455 | 1.62% | |
| ARTV |
Artiva Biotherapeutics, Inc.
Healthcare
|
NEW | 200,000 | $1,940,000 | 1.42% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Held | 26,900 | $1,877,889 | 1.38% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Added | 771,000 | $1,688,490 | 1.24% | |
| CABA |
Cabaletta Bio, Inc.
Healthcare
|
Held | 505,431 | $1,571,890 | 1.15% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 32,700 | $1,403,157 | 1.03% | |
| EOLS |
Evolus, Inc.
Healthcare
|
NEW | 150,000 | $1,041,000 | 0.76% | |
| CELC |
Celcuity Inc.
Healthcare
|
Held | 4,000 | $418,480 | 0.31% | |
| YARW |
Yarrow Bioscience, Inc.
Healthcare
|
Held | 500,551 | $325,858 | 0.24% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.